Behind the Paper
The real stories behind the latest research papers, from conception to publication, the highs and the lows
New players against AML: novel targets with preclinical potencies
Better understanding of AML biology and survival tactics has facilitated a wave of newly approved drugs against AML and also revealed a range of targets to be exploited for treatment. In our review, we discuss what these new targets are and how targeting them in combination might be beneficial.
The story behind the SAVI project
A computer-generated database of a billion+ easily synthesizable molecules aimed at drug design
After the Paper: A new life beyond academia
I recently swapped a career in biochemistry for one in the conservation of Nature, In this ‘After the Paper’ blog I summarise some of the background to my journey from the nanometre scale to the macro scale and some current goals and ambitions.
After the Paper | A new life beyond academia
I recently swapped a career in biochemistry for one in the conservation of Nature, In this ‘After the Paper’ blog I summarise some of the background to my journey from the nanometre scale to the macro scale and some current goals and ambitions.
